tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Trump Weekly: Trump signs pharma order, FTC opens inquiry into AI chatbots
PremiumThe FlyTrump Weekly: Trump signs pharma order, FTC opens inquiry into AI chatbots
11d ago
Advertising, drugmaker stocks in spotlight as Trump moves to regulate pharma ads
Premium
The Fly
Advertising, drugmaker stocks in spotlight as Trump moves to regulate pharma ads
13d ago
Omnicom, WPP under pressure after Trump moves to regulate pharma ads
Premium
The Fly
Omnicom, WPP under pressure after Trump moves to regulate pharma ads
14d ago
BioNTech, Bristol Myers present interim data from a Phase 2 pumitamig trial
PremiumThe FlyBioNTech, Bristol Myers present interim data from a Phase 2 pumitamig trial
16d ago
Hold Recommendation for Bristol-Myers Squibb Due to Cobenfy’s Modest Growth and Revenue Projections
Premium
Ratings
Hold Recommendation for Bristol-Myers Squibb Due to Cobenfy’s Modest Growth and Revenue Projections
16d ago
Private Markets: Anthropic raises $13B Series F at $183B post-money valuation
Premium
The Fly
Private Markets: Anthropic raises $13B Series F at $183B post-money valuation
19d ago
Bristol Myers presents results from COLLIGO-HCM trial at ESC Congress
PremiumThe FlyBristol Myers presents results from COLLIGO-HCM trial at ESC Congress
26d ago
Hold Rating for Bristol-Myers Squibb Amid Uncertain Revenue Projections and Fair Valuation
Premium
Ratings
Hold Rating for Bristol-Myers Squibb Amid Uncertain Revenue Projections and Fair Valuation
30d ago
Bristol-Myers Squibb’s Promising Phase 3 Study on KarXT for Bipolar-I Disorder
Premium
Company Announcements
Bristol-Myers Squibb’s Promising Phase 3 Study on KarXT for Bipolar-I Disorder
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100